Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3969223
Max Phase: Preclinical
Molecular Formula: C46H53ClN8O6S
Molecular Weight: 881.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3969223
Max Phase: Preclinical
Molecular Formula: C46H53ClN8O6S
Molecular Weight: 881.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CCC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cccc4[nH]cnc34)cc2[N+](=O)[O-])CC1
Standard InChI: InChI=1S/C46H53ClN8O6S/c1-46(2)18-15-33(38(27-46)32-7-9-34(47)10-8-32)29-53-21-23-54(24-22-53)35-11-13-37(43(25-35)61-42-6-4-5-40-44(42)50-30-49-40)45(56)51-62(59,60)36-12-14-39(41(26-36)55(57)58)48-28-31-16-19-52(3)20-17-31/h4-14,25-26,30-31,48H,15-24,27-29H2,1-3H3,(H,49,50)(H,51,56)
Standard InChI Key: ZUMPWFPPUYDMOU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 881.50 | Molecular Weight (Monoisotopic): 880.3497 | AlogP: 8.58 | #Rotatable Bonds: 13 |
Polar Surface Area: 166.04 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.17 | CX Basic pKa: 9.26 | CX LogP: 7.02 | CX LogD: 6.23 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.08 | Np Likeness Score: -1.03 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):